GILEAD SCIENCES, INC.

GILD | Nasdaq | CIK: 0000882095 | SIC: 2836 Biological Products, (No Diagnostic Substances) | active
Gilead Sciences, Inc. is a biopharmaceutical company that develops and commercializes medicines across therapeutic areas including HIV, viral hepatitis, oncology, and inflammatory diseases. Key products include BIKTARVY and DESCOVY (HIV), VEKLURY (COVID-19), EPCLUSA and HARVONI (hepatitis C), HEPCLUDEX (hepatitis B), TRODELVY and YESCARTA and TECARTUS (oncology), and LIVDELZI (liver disease).
hivviral-hepatitisoncologyinflammatory-diseases
AI agents: Get this data as structured JSON (~200 tokens):
https://origin.rootz.global/api/company/GILD
Profile | Timeline | SEC Filings | People

Products

NameTypeDescription
BIKTARVYserviceHIV treatment medication
DESCOVY / DESCOVY FOR PREPserviceHIV treatment and pre-exposure prophylaxis medication
VEKLURYserviceAntiviral treatment medication
EPCLUSAserviceHepatitis C treatment medication
HARVONIserviceHepatitis C treatment medication
HEPCLUDEXserviceHepatitis B treatment medication
TRODELVYserviceOncology treatment medication
YESCARTAserviceCAR T-cell therapy for oncology
TECARTUSserviceCAR T-cell therapy for oncology
LIVDELZI / LYVDELZIserviceLiver disease treatment medication

SEC Filings

View all SEC EDGAR filings: EDGAR Company Page

Structured filing index: /api/company/GILD/filings

Origin — Data Provenance
This profile was extracted from SEC EDGAR filings (PEM-signed by sec.gov).
Every API response includes a cryptographic origin leaf for chain-of-custody tracking.
AI Discovery Document | Registry Metrics | GitHub